About
THERAtRAME develops therapeutics that target tRNA epitranscriptomic mechanisms for cancer; the company is affiliated with the University of Liège.
Explore THERAtRAME's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.